How many patents does
Curevac have?
patents
955
families
111
granted
133
applications
822
US
189
EP
151
WO
138
CN
56
JP
49
KR
33
GB
1
RoW
338
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Curevac
Top ten assignees appearing on patents
2009 - 2018
| curevac | 840 |
| reidel, ladislaus | 7 |
| bayer innovation | 4 |
| icon genetics | 3 |
| sanofi pasteur | 3 |
| boehringer ingelheim international | 1 |
| k'jurvehk | 1 |
| acuitas therapeutics | 1 |
| curevac gmbhu | 1 |
2009
| curevac | 28 |
Curevac
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| stabilised tumour-antigen mrna with increased g/c-content | 39 | 2001 |
| complexes of rna and cationic peptides for transfection and for immunostimulation | 38 | 2007 |
| disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic a… 🛈 | 34 | 2009 |
| nucleic acids of formula (i) (nuglxmgnnv)a and derivatives thereof as an immunostimulati… 🛈 | 33 | 2008 |
| composition for treating lung cancer, particularly of non-small lung cancers (nsclc) | 33 | 2007 |
| nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a po… 🛈 | 33 | 2010 |
| nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a po… 🛈 | 28 | 2012 |
| nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a po… 🛈 | 28 | 2012 |
| composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an… 🛈 | 28 | 2008 |
| artificial nucleic acid molecules for improved protein or peptide expression | 27 | 2012 |